Skip to main content
Yunkang Group Limited logo

Yunkang Group Limited — Investor Relations & Filings

Ticker · 2325 ISIN · KYG9889T1067 HKEX Human health and social work activities
Open in API
Filings indexed 1,523 across all filing types
Latest filing 2025-09-03 Share Issue/Capital Cha…
Country HK Hong Kong
Listing HKEX 2325

About Yunkang Group Limited

http://www.yunkanghealth.com

Yunkang Group Limited is a leading medical operation service platform specializing in standardized medical diagnostic services. The company provides comprehensive clinical diagnostic capabilities to collaborative hospitals and integrated healthcare systems (hospital alliances). Its core business lines include diagnostic testing services and diagnostic outsourcing services for medical institutions, as well as diagnostic testing for non-medical clients. Yunkang leverages a nationwide service network and operates independent clinical laboratories (ICLs) across key regions. These ICLs often hold dual international accreditations, such as ISO15189 and CAP, ensuring high-quality, full-range clinical diagnostic support.

Recent filings

Filing Released Lang Actions
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2025
Share Issue/Capital Change Classification · 80% confidence The document is a regulatory submission under HKEX Listing Rule Chapter 19B titled “Monthly Return for Equity Issuer and Hong Kong Depositary Receipts…on Movements in Securities.” It details the company’s authorised, issued, and treasury share movements (i.e., share capital positions) for the month, even though no changes occurred. This is not an annual or quarterly report but a routine capital‐structure disclosure. Among our categories only “Share Issue/Capital Change (SHA)” covers announcements or returns relating to share capital movements. Hence, SHA is the best fit.
2025-09-03 English
CHANGE OF HEAD OFFICE AND PRINCIPAL PLACE OF BUSINESS IN THE PRC
Regulatory Filings Classification · 84% confidence The document is a brief announcement regarding a change of the company’s head office and principal place of business in the PRC. It does not contain financial results, management discussion, proxy materials, or a formal report; rather it is a corporate update. This falls under general regulatory announcements that do not fit other specific categories, so it is classified as RNS (Regulatory Filings).
2025-09-01 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025
Interim / Quarterly Report Classification · 100% confidence The document is an 'Interim Results Announcement' for Yunkang Group Limited for the six months ended June 30, 2025. It contains comprehensive unaudited condensed consolidated financial statements, including the statement of comprehensive income, statement of financial position, and detailed notes to the financial statements. As it provides substantive financial data and analysis for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. H1 2025
2025-08-28 English
DATE OF BOARD MEETING
Regulatory Filings Classification · 85% confidence The document is a stock exchange announcement from Yunkang Group Limited notifying investors of a board meeting date to approve and publish interim results and consider an interim dividend. It does not itself contain financial results (so it’s not an interim report or earnings release), nor is it announcing a report’s publication (so not RPA), nor detailing management changes (so not MANG) or dividends (so not DIV). It falls into the miscellaneous regulatory announcements category (RNS).
2025-08-15 English
FY2025/26 FIRST QUARTER RESULTS ANNOUNCEMENT
Earnings Release Classification · 92% confidence The document is titled “FY2025/26 FIRST QUARTER RESULTS ANNOUNCEMENT” and contains key financial highlights, a summary income statement for the quarter ended June 30, 2025, and a high-level business review by segment. It is an initial, unaudited quarterly financial results announcement (a press release), not a full interim report with detailed audited statements. This matches the definition of an Earnings Release (ER). Q1 2025
2025-08-14 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Governance Information Classification · 90% confidence The document provides Lenovo’s board composition and committee memberships, detailing the company’s governance structure rather than announcing specific board changes. It aligns with ‘Governance Information’ (CGR) which covers board structure and governance practices.
2025-08-14 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.